Ironwood Pharmaceuticals Projects Strong Revenue Growth for 2026
Ironwood Pharmaceuticals forecasts revenue of $450-475M for 2026, driven by Linzess sales growth. Stock surges 28% on positive outlook and pipeline progress.
NOTRELOAD AI
Sable Offshore Nears Oil Restart After Court Decision
Sable Offshore (SOC) shares jump 18% after a federal court allows progress toward restarting its Santa Ynez oil operations, despite ongoing legal challenges.
Trump Delays Furniture Tariff Hikes: Relief for Wayfair and Home Retailers
Trump administration delays furniture tariff increases until 2027. Wayfair, Williams-Sonoma, and RH shares rise as upholstered furniture stays at 25% instead of 30%, cabinets at 25% vs. 50%.
UBS Says Under Armour Is Undervalued and Set for a Comeback
UBS believes Under Armour is undervalued, sees strong brand power, and expects 25% annual earnings growth over the next five years.
Baidu's AI Chip Unit Kunlunxin Files for Hong Kong IPO Amid Chinese Tech Boom
Baidu's AI chip subsidiary Kunlunxin files for Hong Kong listing as Chinese chipmakers capitalize on investor interest and Beijing's push for semiconductor independence from U.S. technology.
Barclays Turns Bullish on Vertiv: Why the Recent Dip Could Be an Opportunity
Barclays upgraded Vertiv stock to Overweight, raised its price target to $200, and sees strong earnings upside in 2026 and 2027 after the recent selloff.